The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?

Fibroblast growth factor 23 (FGF-23) has been associated with increased cardiovascular risk and poor survival in dialysis patients. It is well established that FGF-23 synthesis is directly induced by positive phosphate (P) balance. On the other hand, P-lowering treatments such as nutritional P restr...

Descripción completa

Detalles Bibliográficos
Autores principales: Magagnoli, Lorenza, Cozzolino, Mario, Galassi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Editorial Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539210/
https://www.ncbi.nlm.nih.gov/pubmed/37779858
http://dx.doi.org/10.1093/ckj/sfad144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539210/
https://www.ncbi.nlm.nih.gov/pubmed/37779858
http://dx.doi.org/10.1093/ckj/sfad144

Ejemplares similares